Bond-Based 3D-Chiral Linear Indices: Theory and QSAR Applications to Central Chirality Codification

Abstract

The recently introduced non-stochastic and stochastic bond-based linear indices are been generalized to codify chemical structure information for chiral drugs, making use of a trigonometric 3D-chirality correction factor. These improved modified descriptors are applied to several well-known data sets to validate each one of them. Particularly, Cramer's steroid data set has become a benchmark for the assessment of novel quantitative structure activity relationship methods. This data set has been used by several researchers using 3D-QSAR approaches such as Comparative Molecular Field Analysis, Molecular Quantum Similarity Measures, Comparative Molecular Moment Analysis, E-state, Mapping Property Distributions of Molecular Surfaces, and so on. For that reason, it is selected by us for the sake of comparability. In addition, to evaluate the effectiveness of this novel approach in drug design we model the angiotensin-converting enzyme inhibitory activity of perindoprilate's r-stereoisomers combinatorial library, as well as codify information related to a pharmacological property highly dependent on the molecular symmetry of a set of seven pairs of chiral N-alkylated 3-(3-hydroxyphenyl)-piperidines that bind r-receptors. The validation of this method is achieved by comparison with earlier publications applied to the same data sets. The non-stochastic and stochastic bond-based 3D-chiral linear indices appear to provide a very interesting alternative to other more common 3D-QSAR descriptors. q

Multi-target QPDR classification model for human breast and colon cancer-related proteins using star graph topological indices

“…where N is the number of cases (C and nC), R c is the canonical regression coefficient, U is the Wilk's statistics, F is the Fisher's statistics and p is the p-level (probability of error). The above results are typically considered as excellent in the literature for LDA-QPDR/QSAR models (Castillo-Garit et al, 2008;Estrada and Molina, 2001;Marrero-Ponce et al, 2004;Morales et al, 2006;Vilar et al, 2008). In order to check the variation of this model with the training/CV sets, we carried on a CV study by using ten totally random sets, including the initial one from the actual model (with the same 75% training and 25% CV).…”

Identification In Silico and In Vitro of Novel Trypanosomicidal Drug‐Like Compounds

“…In fact, this scheme has been successfully applied to the prediction of several physical, physicochemical, chemical, pharmacokinetical, toxicological as well as biological properties (20)(21)(22)(23)(24)(25). Furthermore, these molecular descriptors (MDs) have been extended to consider three-dimensional (3D) features of small-⁄ medium-sized molecules based on the trigonometric-3D-chirality-correction factor approach (26)(27)(28)(29)(30)(31).…”